✦ LIBER ✦

Bosutinib: a dual SRC/ABL kinase inhibitor for the treatment of chronic myeloid leukemia

✍ Scribed by Keller, Gunhild; Schafhausen, Philippe; Brummendorf, Tim H

Book ID: 121089768
Publisher: Expert Reviews
Year: 2009
Tongue: English
Weight: 321 KB
Volume: 2
Category: Article
ISSN: 1747-4086
DOI: 10.1586/ehm.09.42

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Novel aspects of therapy with the dual S

Novel aspects of therapy with the dual Src and Abl kinase inhibitor bosutinib in chronic myeloid leukemia

✍ Keller-v.Amsberg, Gunhild ;Brümmendorf, Tim H 📂 Article 📅 2012 🏛 Expert Reviews 🌐 English ⚖ 672 KB

Global target profile of the kinase inhi

Global target profile of the kinase inhibitor bosutinib in primary chronic myeloid leukemia cells

✍ Remsing Rix, L L; Rix, U; Colinge, J; Hantschel, O; Bennett, K L; Stranzl, T; Mü 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 505 KB

Importance of adherence to BCR-ABL tyros

Importance of adherence to BCR-ABL tyrosine-kinase inhibitors in the treatment of chronic myeloid leukemia

✍ de Almeida, Maria Helena; Fogliatto, Laura; Couto, Dulce 📂 Article 📅 2014 🏛 SciELO 🌐 English ⚖ 170 KB

Second-generation BCR-ABL inhibitors for

Second-generation BCR-ABL inhibitors for frontline treatment of chronic myeloid leukemia in chronic phase

✍ Gianantonio Rosti; Fausto Castagnetti; Gabriele Gugliotta; Francesca Palandri; M 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 156 KB

Efficacy and Safety of a Specific Inhibi

Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia

✍ Druker, Brian J.; Talpaz, Moshe; Resta, Debra J.; Peng, Bin; Buchdunger, Elisabe 📂 Article 📅 2001 🏛 Massachusetts Medical Society 🌐 English ⚖ 177 KB

Class effects of tyrosine kinase inhibit

Class effects of tyrosine kinase inhibitors in the treatment of chronic myeloid leukemia

✍ Giles, F J; O'Dwyer, M; Swords, R 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 315 KB